Quote | 4D pharma plc (NASDAQ:LBPS)
Last: | $1.65 |
---|---|
Change Percent: | 2.48% |
Open: | $1.61 |
Close: | $1.65 |
High: | $1.65 |
Low: | $1.61 |
Volume: | 3,914 |
Last Trade Date Time: | 06/24/2022 04:38:34 am |
News | 4D pharma plc (NASDAQ:LBPS)
Since the invasion, my funds in Russia have been frozen. I don’t believe central banks really have the will to have very high levels of bankruptcy/unemployment/social conflict. The main concern with oil/gas companies is that the managements insist on reinvestment/growth and...
4D pharma (NASDAQ:LBPS) on Tuesday said it had been notified by Nasdaq that trading in its stock would be suspended on July 7 and that its securities would be delisted after that. The Nasdaq notification comes a week after lender Oxford Finance placed LBPS into administration following the in...
Message Board Posts | 4D pharma plc (NASDAQ:LBPS)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC (ȁ...
4D pharma plc (AIM: DDDD, Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, provides an update to the announcement released earlier today regarding the Company’s request for a...
- Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months - Study sites are open for patient enrolment 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) , a pharmaceutical company leading the development of Live Biotherapeutic products (LB...